Livforsakringsbolaget Skandia Omsesidigt Purchases 1,100 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Livforsakringsbolaget Skandia Omsesidigt grew its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 282.1% during the 3rd quarter, Holdings Channel.com reports. The firm owned 1,490 shares of the company’s stock after acquiring an additional 1,100 shares during the period. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Henry Schein were worth $109,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. Summit Securities Group LLC bought a new position in Henry Schein during the 2nd quarter worth approximately $31,000. Beach Investment Counsel Inc. PA bought a new position in Henry Schein during the 2nd quarter worth approximately $37,000. Blue Trust Inc. grew its position in Henry Schein by 104.2% during the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after acquiring an additional 475 shares during the last quarter. Mather Group LLC. grew its position in Henry Schein by 16.8% during the 2nd quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock worth $96,000 after acquiring an additional 216 shares during the last quarter. Finally, Palisade Asset Management LLC bought a new position in Henry Schein during the 1st quarter worth approximately $113,000. 96.62% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Baird R W upgraded Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. Barrington Research reiterated an “outperform” rating and issued a $82.00 price objective on shares of Henry Schein in a research report on Friday, September 20th. UBS Group cut their price objective on Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 7th. Piper Sandler reiterated an “overweight” rating and issued a $86.00 price objective on shares of Henry Schein in a research report on Friday, June 21st. Finally, JPMorgan Chase & Co. cut their price objective on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research report on Monday, August 12th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Henry Schein presently has an average rating of “Hold” and an average price target of $77.50.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.14% of the stock is owned by company insiders.

Henry Schein Trading Up 0.1 %

HSIC opened at $71.10 on Wednesday. The stock has a market cap of $9.10 billion, a PE ratio of 24.02, a PEG ratio of 1.98 and a beta of 0.86. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46. The business has a 50 day moving average of $69.99 and a 200-day moving average of $69.92. Henry Schein, Inc. has a 52 week low of $60.01 and a 52 week high of $82.63.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. The business had revenue of $3.10 billion during the quarter, compared to analysts’ expectations of $3.27 billion. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The firm’s quarterly revenue was up .0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.31 earnings per share. Equities research analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.